Back to results
US 7,611,729 B2Granted
Dosage forms having prolonged active ingredient release
AssigneeLunamed AG
InventorPeter Truog
Life of this patent
Estimating the term…
Abstract
The present invention relates to prolonged-release oral dosage forms of 4-phenylbutyric acid salts, such as sodium 4-phenylbutyrate. The prolonged release oral dosage forms are preferably tablets. The prolonged release is achieved by formulating 4-phenylbutyric acid with a delaying matrix material, such as hydroxypropylmethyl cellulose. The prolonged release oral dosage forms of the present invention may be administered once or twice a day to a patient suffering from a disease such as cancer or a urea cycle disorder.
Claims6
A prolonged release oral pharmaceutical dosage form of a 4-phenylbutyric acid salt comprising:
- 250 mg of a 4-phenylbutyric acid salt;
- wherein the dosage form comprises 146 mg of hydroxypropylmethylcellulose, 261 mg of lactose, 30 to 60 mg of microcrystalline cellulose, 10 mg of hardened vegetable oil or talcum, 1.5 mg of magnesium stearate, and optionally about 1 mg of highly dispersed silicon dioxide, that permits a rate of release of 4-phenylbutyric acid during a period of about 6 to 24 hours.
Dependencies are inferred from the claim text.